We are live on ! Find out more
SPRO icon

Spero Therapeutics
SPRO

61 hedge funds and large institutions have $104M invested in Spero Therapeutics in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 11

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

3% more funds holding

Funds holding: 59 → 61 (+2)

0.94% more ownership

Funds ownership: 55.6% → 56.54% (+0.94%)

5% less capital invested

Capital invested by funds: $110M → $104M (-$5.98M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
61
Holders Change
+2
Holders Change %
+3.39%
% of All Funds
1.2%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
8
Increased
28
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
+$5.02M
2
Renaissance Technologies
Renaissance Technologies
New York
+$921K
3
BlackRock
BlackRock
New York
+$823K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$386K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$350K

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$1.34M
2
BI
BVF Inc
California
-$1.02M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$773K
4
AG
Artal Group
Luxembourg
-$431K
5
DCM
DAFNA Capital Management
California
-$418K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
51
Citigroup
New York
$23K +$11.9K +1,108 +86%
Ohio Public Employees Retirement System (OPERS)
52
Ohio Public Employees Retirement System (OPERS)
Ohio
$23K +$26K +2,415 New
Legal & General Group
53
Legal & General Group
United Kingdom
$20K – – –
Bank of Montreal
54
Bank of Montreal
Ontario, Canada
$13K +$4.32K +401 +42%
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
$12K +$9.66K +896 +299%
PCM
56
Prelude Capital Management
New York
$9K +$2.16K +200 +29%
RE
57
RBC Europe
United Kingdom
$5.75K – – –
AIP
58
Ameritas Investment Partners
Nebraska
$5K – – –
MAM
59
Meeder Asset Management
Ohio
$5K – – –
US Bancorp
60
US Bancorp
Minnesota
$5K – – –
GI
61
Gradient Investments
Minnesota
$2K +$1.91K +177 New
DCM
62
DAFNA Capital Management
California
– -$418K -39,395 Closed
Susquehanna International Group
63
Susquehanna International Group
Pennsylvania
– -$117K -11,063 Closed
Victory Capital Management
64
Victory Capital Management
Texas
– -$21K -1,988 Closed
TRCT
65
Tower Research Capital (TRC)
New York
– -$2K -223 Closed
TFA
66
Toth Financial Advisory
Virginia
– -$2K -150 Closed
Group One Trading
67
Group One Trading
Illinois
– -$1K -100 Closed
1 2
3

SPRO Hedge Fund Activity: Q4 2019 in Review

61 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Spero Therapeutics (SPRO) for Q4 2019, worth a combined $104M — down 5.4% from $110M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new SPRO positions and 6 closed out — a net gain of 2 holders — while 28 added to existing stakes and 11 trimmed.

The largest buyer was Novo Holdings A/S, adding an estimated $5.02M. The largest seller was AWM Investment Company, cutting an estimated $1.34M.

  • 61 institutional investors held Spero Therapeutics (SPRO) as of Q4 2019, up from 59 in Q3 2019.
  • Funds reported $104M of Spero Therapeutics stock for Q4 2019, down 5.4% quarter-over-quarter.
  • 8 funds opened new Spero Therapeutics positions in Q4 2019 and 6 closed out, a net change of +2 holders.
  • The largest Spero Therapeutics buyer in Q4 2019 was Novo Holdings A/S, an estimated $5.02M added.
  • The largest Spero Therapeutics seller in Q4 2019 was AWM Investment Company, an estimated $1.34M sold.

Based on aggregated 13F filings for Q4 2019.